Trump Administration Will Fund New Research on Controversial Psychedelic Drug Ibogaine
The money will fund manufacturing, dosing and study design as federal agencies prepare safety-focused research on the illegal psychedelic.
- On Thursday, Health Secretary Robert F. Kennedy Jr. announced the government is awarding up to $4.9 million for the first U.S. studies of ibogaine to treat post-traumatic stress disorder in veterans.
- President Donald Trump's April executive order accelerating psychedelic research launched the initiative after podcaster Joe Rogan discussed ibogaine's potential benefits with the president.
- Veterans Affairs Secretary Doug Collins, who joined Kennedy for the announcement, said the collaborative effort would focus on 'best-in-class research.' The government will use data from Beond Inc., a Texas-based company that has treated more than 3,000 patients in Mexico.
- Currently classified as an illegal substance, ibogaine carries significant safety risks including irregular heart rhythms. Clinics typically charge $10,000 to $20,000 per treatment course, which requires emergency medical monitoring.
- Kennedy stated, "We're going to have, I think, a record drug approval process," as officials aim to accelerate clinical trials. Additional funding awards may explore ibogaine's use for addiction treatment.
34 Articles
34 Articles
Trump administration will fund new research on controversial psychedelic drug ibogaine - WXXV News 25
President Donald Trump signs an executive order in the Oval Office of the White House, Saturday, April 18, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson, File)By MATTHEW PERRONE WASHINGTON (AP) — Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald...
Trump Administration Will Fund New Research on a Controversial Psychedelic Drug
“That is going to allow us to dramatically accelerate the clinical trial process,” Health Secretary Robert F. Kennedy Jr. said. (Tom Williams/CQ Roll Call via AP Images)Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.Health Secretary Robert F. Kennedy Jr. said his dep…
US to fund new research into psychedelic drug ibogaine for veterans with PTSD - Regional Media News
Nov 12 (Reuters) - The US government will spend up to $4.9 million to prepare for clinical trials of psychedelic drug ibogaine as a possible treatment for veterans with post-traumatic stress disorder (PTSD), Health Secretary Robert F. Kennedy Jr. said on Thursday. President Donald Trump [...]
Trump administration fast-tracks ibogaine research for PTSD
The Trump administration announced on Thursday a multi-department investment in fast-tracking research for the psychotropic drug ibogaine to treat post-traumatic stress disorder and other serious mental illnesses. Health and Human Services Secretary Robert F. Kennedy Jr. announced a more than $25 million investment from his department, along with the Department of Veterans Affairs, to speed […]
Coverage Details
Bias Distribution
- 43% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
